Cargando…
Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective
Lymphangioleiomyomatosis (LAM) is a rare lung disease that almost exclusively affects women and develops in about one in 400 000 adult females. The European Lung Foundation worked closely with one of the patient organisations within its network, the European LAM Federation, to raise awareness of LAM...
Autores principales: | Bassi, Iris, Hollis, Gill, Cottin, Vincent, Harari, Sergio, Zwanenburg, Elma, Veltkamp, Marcel, Casanova, Alvaro, Fletcher, Monica, Masefield, Sarah, Powell, Pippa, Boyd, Jeanette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005183/ https://www.ncbi.nlm.nih.gov/pubmed/27730199 http://dx.doi.org/10.1183/23120541.00102-2015 |
Ejemplares similares
-
Air travel and incidence of pneumothorax in lymphangioleiomyomatosis
por: Gonano, Cynthia, et al.
Publicado: (2018) -
Communication difficulties reported by patients diagnosed with idiopathic pulmonary fibrosis and their carers: a European focus group study
por: Masefield, Sarah, et al.
Publicado: (2019) -
New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
por: Torre, Olga, et al.
Publicado: (2017) -
Lymphangioleiomyomatosis diagnosed by effusion cytology: A case report
por: Rivera, Glorimar, et al.
Publicado: (2015) -
“Patients Included” in the European Respiratory Society International Congress
por: Smyth, Dan, et al.
Publicado: (2015)